Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
- PMID: 33835768
- PMCID: PMC8112568
- DOI: 10.1056/NEJMoa2104882
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Abstract
We report findings in five patients who presented with venous thrombosis and thrombocytopenia 7 to 10 days after receiving the first dose of the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19). The patients were health care workers who were 32 to 54 years of age. All the patients had high levels of antibodies to platelet factor 4-polyanion complexes; however, they had had no previous exposure to heparin. Because the five cases occurred in a population of more than 130,000 vaccinated persons, we propose that they represent a rare vaccine-related variant of spontaneous heparin-induced thrombocytopenia that we refer to as vaccine-induced immune thrombotic thrombocytopenia.
Copyright © 2021 Massachusetts Medical Society.
Figures
Comment in
-
How could a COVID vaccine cause blood clots? Scientists race to investigate.Nature. 2021 Apr;592(7854):334-335. doi: 10.1038/d41586-021-00940-0. Nature. 2021. PMID: 33846607 No abstract available.
-
Incidence of cerebral venous thrombosis and COVID-19 vaccination: possible causal effect or just chance?Eur Heart J Cardiovasc Pharmacother. 2021 Jul 23;7(4):e77-e78. doi: 10.1093/ehjcvp/pvab036. Eur Heart J Cardiovasc Pharmacother. 2021. PMID: 33930114 Free PMC article. No abstract available.
-
Double high-dose immunoglobulin for ChAdOx1 nCov-19 vaccine-induced immune thrombotic thrombocytopenia.Thromb Res. 2021 Oct;206:14-17. doi: 10.1016/j.thromres.2021.07.017. Epub 2021 Aug 4. Thromb Res. 2021. PMID: 34375780 Free PMC article. No abstract available.
-
Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study.Thromb Res. 2021 Dec;208:1-3. doi: 10.1016/j.thromres.2021.10.002. Epub 2021 Oct 9. Thromb Res. 2021. PMID: 34649161 Free PMC article. No abstract available.
-
VITT after ChAdOx1 nCoV-19 Vaccination.N Engl J Med. 2021 Dec 2;385(23):2202-2203. doi: 10.1056/NEJMc2111026. Epub 2021 Nov 3. N Engl J Med. 2021. PMID: 34731555 No abstract available.
-
VITT after ChAdOx1 nCoV-19 Vaccination.N Engl J Med. 2021 Dec 2;385(23):2203-2204. doi: 10.1056/NEJMc2111026. Epub 2021 Nov 3. N Engl J Med. 2021. PMID: 34731556 No abstract available.
Similar articles
-
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9. N Engl J Med. 2021. PMID: 33835769 Free PMC article.
-
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.N Engl J Med. 2021 Jun 10;384(23):2202-2211. doi: 10.1056/NEJMoa2105385. Epub 2021 Apr 16. N Engl J Med. 2021. PMID: 33861525 Free PMC article.
-
Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2.Blood. 2021 Jul 29;138(4):299-303. doi: 10.1182/blood.2021012217. Blood. 2021. PMID: 33988688 Free PMC article.
-
The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.Clin Chim Acta. 2022 Apr 1;529:42-45. doi: 10.1016/j.cca.2022.02.003. Epub 2022 Feb 12. Clin Chim Acta. 2022. PMID: 35167842 Free PMC article. Review.
-
Perspectives on vaccine induced thrombotic thrombocytopenia.J Autoimmun. 2021 Jul;121:102663. doi: 10.1016/j.jaut.2021.102663. Epub 2021 May 18. J Autoimmun. 2021. PMID: 34020254 Free PMC article. Review.
Cited by
-
Bridging gene therapy and next-generation vaccine technologies.Gene Ther. 2024 Nov 18. doi: 10.1038/s41434-024-00502-9. Online ahead of print. Gene Ther. 2024. PMID: 39558149 Review. No abstract available.
-
A Lassa virus live attenuated vaccine candidate that is safe and efficacious in guinea pigs.NPJ Vaccines. 2024 Nov 17;9(1):220. doi: 10.1038/s41541-024-01012-w. NPJ Vaccines. 2024. PMID: 39551823 Free PMC article.
-
Non-COVID Admissions to the ICU After COVID Vaccination: A Multicenter Study.Cureus. 2024 Oct 15;16(10):e71534. doi: 10.7759/cureus.71534. eCollection 2024 Oct. Cureus. 2024. PMID: 39544616 Free PMC article.
-
Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination.Sci Rep. 2024 Oct 18;14(1):24512. doi: 10.1038/s41598-024-75514-x. Sci Rep. 2024. PMID: 39424883 Free PMC article.
-
Deciphering changes in the incidence of hemorrhagic stroke and cerebral venous sinus thrombosis during the coronavirus disease 2019 pandemic: A nationwide time-series correlation study.PLoS One. 2024 Oct 3;19(10):e0301313. doi: 10.1371/journal.pone.0301313. eCollection 2024. PLoS One. 2024. PMID: 39361618 Free PMC article.
References
-
- WHO Coronavirus (COVID-19) Dashboard. Geneva: World Health Organization. April 5, 2021. (https://covid19.who.int/).
-
- Norwegian Institute of Public Health. COVID 19 Ukerapport — uke 10, March 17, 2021. (https://www.fhi.no/contentassets/8a971e7b0a3c4a06bdbf381ab52e6157/vedleg...).
-
- Warkentin TE, Sheppard JI, Moore JC, Kelton JG. The use of well-characterized sera for the assessment of new diagnostic enzyme-immunoassays for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 2010;8:216-218. - PubMed
-
- Galea V, Khaterchi A, Robert F, Gerotziafas G, Hatmi M, Elalamy I. Heparin-induced multiple electrode aggregometry is a promising and useful functional tool for heparin-induced thrombocytopenia diagnosis: confirmation in a prospective study. Platelets 2013;24:441-447. - PubMed
-
- Morel-Kopp MC, Mullier F, Gkalea V, et al. Heparin-induced multi-electrode aggregometry method for heparin-induced thrombocytopenia testing: communication from the SSC of the ISTH. J Thromb Haemost 2016;14:2548-2552. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical